RBC Capital initiates United Therapeutics stock with Outperform rating
PositiveFinancial Markets

RBC Capital has given United Therapeutics an Outperform rating, signaling strong confidence in the company's future performance. This endorsement is significant as it may attract more investors and boost the stock's value, reflecting optimism about United Therapeutics' growth potential in the biotech sector.
— Curated by the World Pulse Now AI Editorial System